Why Parents Are Turning to a Controversial Treatment for Food Allergies

August 20, 2019

(Undark) – Over the past decade, the number of OIT providers has grown from just a handful of doctors nationwide to a small, influential cohort of more than a hundred today. Thousands of food allergy patients who have tried oral immunotherapy in the United States and abroad swear by the treatment, often calling the results life-changing. And with an FDA decision expected by early 2020 for Aimmune Therapeutics’ “peanut capsules,” OIT could soon go mainstream.  But at the moment, allergists remain deeply divided over the treatment, which doesn’t work for everyone and carries uncertain risks.

Recommended Reading